(Q40464141)

20 September 2017

title

Cytomegalovirus infection in renal transplant recipients. (English)

1 reference

20 September 2017

0 references

cytomegaloviral disease

1 reference

Carstens J

1

1 reference

20 September 2017

Andersen HK

series ordinal

2

1 reference

20 September 2017

Spencer E

series ordinal

3

1 reference

20 September 2017

Madsen M

series ordinal

4

1 reference

20 September 2017

publication date

1 December 2006

1 reference

Transplant Infectious Disease

20 September 2017

published in

1 reference

20 September 2017

volume

8

1 reference

20 September 2017

issue

4

1 reference

20 September 2017

page(s)

203-212

1 reference

The impact of cytomegalovirus infection and disease on rejection episodes in renal allograft recipients

20 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplant recipients by a real-time PCR assay performed with blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Meta-analysis of prophylaxis of CMV disease in solid organ transplantation: is Ganciclovir a superior agent to Acyclovir?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Definitions of cytomegalovirus infection and disease in transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

A longitudinal prospective study of cytomegalovirus pp65 antigenemia in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

The impact of early cytomegalovirus infection and disease in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Outcome of low-dose ganciclovir for cytomegalovirus disease prophylaxis in renal-transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

A randomized prospective controlled trial of oral ganciclovir versus oral valacyclovir for prophylaxis of cytomegalovirus disease after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Cytomegalovirus disease after prophylaxis with oral ganciclovir in renal transplantation: the importance of HLA-DR matching

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Allograft rejection predicts the occurrence of late-onset cytomegalovirus (CMV) disease among CMV-mismatched solid organ transplant patients receiving prophylaxis with oral ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Management of cytomegalovirus infection by weekly surveillance after renal transplant: analysis of cost, rejection and renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Cytomegalovirus infection in solid organ transplantation: economic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Clinical course of cytomegalovirus (CMV) viremia with and without ganciclovir treatment in CMV-seropositive kidney transplant recipients. Longitudinal follow-up of CMV pp65 antigenemia assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Infections and solid organ transplant rejection: a cause-and-effect relationship?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

Prevention of recurrent cytomegalovirus disease in renal and liver transplant recipients: effect of oral ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3062.2006.00169.X

10.1111/J.1399-3062.2006.00169.X

21 January 2018

Identifiers

DOI

1 reference

20 September 2017

1 reference